Human Papillomavirus (HPV) InfectionNCT07420556
Effect of Different HPV Education Methods on Vaccination Intention in Young Women
A study testing Video-Based HPV Education and Face-to-Face HPV Education in people with Human Papillomavirus (HPV) Infection and HPV Vaccination Acceptance/Intention, run by Emel GÜÇLÜ CİHAN at 1 site in Turkey (Türkiye).
Trial summary
Detailed Description Human papillomavirus (HPV) is one of the leading causes of cervical cancer and can be prevented by vaccination. However, HPV vaccination rates among young women are low, largely due to insufficient knowledge and misconceptions about HPV and the vaccine. Read more about this study
- Who is it for?
- Ages 18 to 24 years, women onlyHealthy volunteers can take part
- Conditions the study is for
- Human Papillomavirus (HPV) Infection, HPV Vaccination Acceptance/Intention
- What is being tested?
- Video-Based HPV Education and Face-to-Face HPV Education
- Type of treatment
- Vaccines, Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 159 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 15 Dec 2025to 14 May 2026
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 24 years
- Women only
- Healthy volunteers accepted
- Adult
Who may be able to join
- Participants must meet all of the following criteria to be included in the study:
- Aged 18-24 years,
- Residing in Afşin district, Kahramanmaraş province,
- Willing to voluntarily participate in the study,
- Literate and able to understand survey questions in Turkish,
- Have not previously received the HPV vaccine,
- Agree to be available throughout the study period (pre-test, post-education test, and 1-month follow-up test),
- Young women without physical or cognitive impairments or serious health problems that would prevent participation in the study.
Who cannot join
- Participants will be excluded if they meet any of the following conditions:
- Under 18 or over 24 years of age,
- Have received the HPV vaccine or started the vaccine series,
- Have been diagnosed with HPV infection,
- Unable to attend the educational sessions or complete all stages of data collection (pre-test, post-education test, 1-month follow-up test),
- Illiterate or unable to understand the study forms in Turkish,
- Withdraw from the study or indicate unwillingness to continue participation,
- Have serious hearing, vision, or cognitive impairments that would prevent meaningful engagement in the educational sessions.
Trial locations and contacts
1 site in 1 country.
About this study
Official title: The Effect of Delivering HPV Education Through Different Methods on Young Women's Intention to Receive the Vaccine: A Randomized Controlled Trial
Detailed Description Human papillomavirus (HPV) is one of the leading causes of cervical cancer and can be prevented by vaccination. However, HPV vaccination rates among young women are low, largely due to insufficient knowledge and misconceptions about HPV and the vaccine. Therefore, an effective educational program may improve both knowledge and vaccination intention.
The aim of this randomized controlled trial is to examine the effect of delivering HPV education through different methods (asynchronous online education delivered via a pre-recorded video and face-to-face education) on HPV knowledge level and HPV vaccination intention among women aged 18-24 years.
Read more
The study will be conducted with women aged 18-24 years registered at Family Health Centers in the Afşin district of Kahramanmaraş, Türkiye. Eligible participants will be randomly assigned into three groups: the video-based education group, the face-to-face education group, and the control group.
Data will be collected using the Participant Information Form, HPV Knowledge Scale, and HPV Vaccination Attitude and Intention Form. Measurements will be performed at three time points: before the education (pre-test), immediately after the education (post-test), and one month after the education (follow-up test). The video-based education group will receive the education via a pre-recorded online video, while the face-to-face group will receive the same content in person at the Family Health Center. No education will be provided to the control group; only measurements will be obtained.
Research Questions
Does HPV education delivered through different methods increase HPV knowledge levels among young women?
Does HPV education increase HPV vaccination intention compared with the control group?
Is face-to-face education more effective than video-based education in increasing vaccination intention?
Are the improvements in knowledge and vaccination intention sustained one month after the education?
Read the detailed description
This study is a randomized controlled intervention designed to evaluate the effects of different educational methods on HPV and HPV vaccination knowledge level and vaccination intention among young women aged 18-24 living in the Afşin district of Kahramanmaraş, Türkiye. Participants will be randomly assigned into three groups: control group, video-based education group, and face-to-face education group.
At the beginning of the study, a pre-test will be administered to determine participants' baseline HPV and HPV vaccine knowledge and vaccination intention. Educational interventions prepared in accordance with national health guidelines will be delivered to the intervention groups, while no training will be provided to the control group. Immediately after the education sessions, a post-test will be applied to assess short-term effects, and a follow-up assessment one month later will evaluate the persistence of the effect.
Data will be collected at three time points using an introductory information form, the HPV Knowledge Scale, and the HPV Vaccination Attitude and Intention Form. The findings will be used to compare the effectiveness of different educational methods on HPV knowledge level and vaccination intention.
- Being tested
- Video-Based HPV Education, Face-to-Face HPV Education
- Keywords
- HPV, HPV vaccination, HPV vaccine acceptance, preventive health behavior, health education
- Medical subject headings
- Papillomavirus Infections, Infections, Health Education
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Video-Based HPV EducationBehavioural
A structured educational video providing information about HPV infection, transmission, prevention, and HPV vaccination.
Face-to-Face HPV EducationBehavioural
A structured face-to-face educational session conducted by the researcher covering HPV infection, transmission, prevention, and HPV vaccination.
Video-Based HPV EducationBehavioural
Participants will receive HPV and HPV vaccination education through a standardized educational video including information about HPV transmission, related diseases, prevention methods, and the benefits of vaccination.
Face-to-Face HPV EducationBehavioural
Participants will receive HPV and HPV vaccination education through a structured face-to-face session conducted by the researcher using standardized educational materials.
| Study group | Role | What they receive |
|---|---|---|
| Control Group | No intervention | Participants in this group will not receive any HPV education during the study period and will complete the same assessments as the intervention groups at all measurement time points. |
| Video-Based Education Group | Experimental | Participants in this group will receive HPV and HPV vaccination education delivered through a standardized educational video prepared in accordance with national health guidelines. Receives: Behavioral: Video-Based HPV Education |
| Face-to-Face Education Group | Experimental | Participants in this group will receive HPV and HPV vaccination education through face-to-face training provided by the researcher using standardized educational materials. Receives: Behavioral: Face-to-Face HPV Education |
What is being measured
The primary outcome is the main question the study is designed to answer.
HPV Knowledge and Vaccination Intention - Pre-Test
Young women who consent to participate in the study will complete the Participant Information Form and the HPV Knowledge and Vaccination Intention Scale before receiving any education. This stage aims to determine participants' baseline knowledge and intention to vaccinate.
Measured: Before education
Secondary outcomes (2)
HPV Knowledge and Vaccination Intention - Post-Education Test
Immediately after the intervention, the experimental groups will receive the designated educational methods (video-based education and face-to-face education), and the same scales will be re-administered. This measurement is intended to evaluate the short-term effect of the education. The control group will not receive any education at this stage, only the assessments will be conducted.
Measured: Immediately after education
HPV Knowledge and Vaccination Intention - 1-Month Follow-Up Test
One month after the educational intervention, all groups will complete the same scales again to assess the persistence of changes in knowledge and vaccination intention. This measurement evaluates the sustained effect of the educational interventions.
Measured: : 1 month after education
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted19 Feb 2026
- Study start15 Dec 2025
- Primary completion15 Jan 2026
- Study completion14 May 2026
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Human Papillomavirus (HPV) InfectionStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- Participants will be randomly assigned to one of three parallel groups: a control group, a video-based education group, or a face-to-face education group. Each participant will remain in the assigned group throughout the study, and outcomes will be compared between groups across three measurement time points (baseline, immediately after the intervention, and one-month follow-up).
- Masking
- None (open label)
- Enrolment
- 159 participants (actual)
Sponsor and investigators
- Lead sponsor
- Emel GÜÇLÜ CİHAN
- Sponsor type
- University, hospital or other
- Collaborators
- Kahramanmaras Sutcu Imam University
- Responsible party
- Sponsor-investigator, Emel GÜÇLÜ CİHAN, Kahramanmaras Sutcu Imam University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07420556
- Sponsor's protocol ID
- HPV-EDU-2026-RCT
- Status last verified
- Feb 2026
- First submitted
- 12 Feb 2026
- Last updated
- 19 Aug 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: Individual participant data will not be shared because the dataset contains sensitive personal information related to participants' health, vaccination intention, and demographic details. To protect participant confidentiality and privacy, access to the data is restricted to the research team.
Study at a glance
From the registry record, last updated by the sponsor on 19 Aug 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Effect of Delivering HPV Education Through Different Methods on Young Women's Intention to Receive the Vaccine: A Randomized Controlled Trial
- ClinicalTrials.gov ID
- NCT07420556
- Acronym / sponsor ID
- HPV-EDU-2026-RCT
- Keywords
- HPV, HPV vaccination, HPV vaccine acceptance, preventive health behavior, health education
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 159 participants (actual)
- Lead sponsor
- Emel GÜÇLÜ CİHANUniversity, hospital or other
- Collaborators
- Kahramanmaras Sutcu Imam University
- Study start
- 15 Dec 2025 (actual)
- Primary completion
- 15 Jan 2026 (actual)
- Study completion
- 14 May 2026 (actual)
- First posted
- 19 Feb 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Detailed Description Human papillomavirus (HPV) is one of the leading causes of cervical cancer and can be prevented by vaccination. However, HPV vaccination rates among young women are low, largely due to insufficient knowledge and misconceptions about HPV and the vaccine. Therefore, an effective educational program may improve both knowledge and vaccination intention.
The aim of this randomized controlled trial is to examine the effect of delivering HPV education through different methods (asynchronous online education delivered via a pre-recorded video and face-to-face education) on HPV knowledge level and HPV vaccination intention among women aged 18-24 years.
The study will be conducted with women aged 18-24 years registered at Family Health Centers in the Afşin district of Kahramanmaraş, Türkiye. Eligible participants will be randomly assigned into three groups: the video-based education group, the face-to-face education group, and the control group.
Data will be collected using the Participant Information Form, HPV Knowledge Scale, and HPV Vaccination Attitude and Intention Form. Measurements will be performed at three time points: before the education (pre-test), immediately after the education (post-test), and one month after the education (follow-up test). The video-based education group will receive the education via a pre-recorded online video, while the face-to-face group will receive the same content in person at the Family Health Center. No education will be provided to the control group; only measurements will be obtained.
Research Questions
Does HPV education delivered through different methods increase HPV knowledge levels among young women?
Does HPV education increase HPV vaccination intention compared with the control group?
Is face-to-face education more effective than video-based education in increasing vaccination intention?
Are the improvements in knowledge and vaccination intention sustained one month after the education?
Detailed description
This study is a randomized controlled intervention designed to evaluate the effects of different educational methods on HPV and HPV vaccination knowledge level and vaccination intention among young women aged 18-24 living in the Afşin district of Kahramanmaraş, Türkiye. Participants will be randomly assigned into three groups: control group, video-based education group, and face-to-face education group.
At the beginning of the study, a pre-test will be administered to determine participants' baseline HPV and HPV vaccine knowledge and vaccination intention. Educational interventions prepared in accordance with national health guidelines will be delivered to the intervention groups, while no training will be provided to the control group. Immediately after the education sessions, a post-test will be applied to assess short-term effects, and a follow-up assessment one month later will evaluate the persistence of the effect.
Data will be collected at three time points using an introductory information form, the HPV Knowledge Scale, and the HPV Vaccination Attitude and Intention Form. The findings will be used to compare the effectiveness of different educational methods on HPV knowledge level and vaccination intention.
Study design
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 3
- Model description
- Participants will be randomly assigned to one of three parallel groups: a control group, a video-based education group, or a face-to-face education group. Each participant will remain in the assigned group throughout the study, and outcomes will be compared between groups across three measurement time points (baseline, immediately after the intervention, and one-month follow-up).
| Arm | Type | Receives |
|---|---|---|
| Control Group | No intervention | –Participants in this group will not receive any HPV education during the study period and will complete the same assessments as the intervention groups at all measurement time points. |
| Video-Based Education Group | Experimental | Behavioral: Video-Based HPV EducationParticipants in this group will receive HPV and HPV vaccination education delivered through a standardized educational video prepared in accordance with national health guidelines. |
| Face-to-Face Education Group | Experimental | Behavioral: Face-to-Face HPV EducationParticipants in this group will receive HPV and HPV vaccination education through face-to-face training provided by the researcher using standardized educational materials. |
Who may qualify
- Ages
- 18 to 24 years
- Sex
- Female only
- Healthy volunteers
- Accepted
- Age groups
- Adult
Key inclusion criteria (8 listed)
- Aged 18-24 years,
- Residing in Afşin district, Kahramanmaraş province,
- Willing to voluntarily participate in the study,
- Literate and able to understand survey questions in Turkish,
- Have not previously received the HPV vaccine,
Key exclusion criteria (8 listed)
- Under 18 or over 24 years of age,
- Have received the HPV vaccine or started the vaccine series,
- Have been diagnosed with HPV infection,
- Unable to attend the educational sessions or complete all stages of data collection (pre-test, post-education test, 1-month follow-up test),
- Illiterate or unable to understand the study forms in Turkish,
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Video-Based HPV EducationA structured educational video providing information about HPV infection, transmission, prevention, and HPV vaccination. | Behavioural | Video-Based Education Group |
| Face-to-Face HPV EducationA structured face-to-face educational session conducted by the researcher covering HPV infection, transmission, prevention, and HPV vaccination. | Behavioural | Face-to-Face Education Group |
| Video-Based HPV EducationParticipants will receive HPV and HPV vaccination education through a standardized educational video including information about HPV transmission, related diseases, prevention methods, and the benefits of vaccination. | Behavioural | Video-Based Education Group |
| Face-to-Face HPV EducationParticipants will receive HPV and HPV vaccination education through a structured face-to-face session conducted by the researcher using standardized educational materials. | Behavioural | Face-to-Face Education Group |
Primary outcome
HPV Knowledge and Vaccination Intention - Pre-Test
Time frame: Before education
Young women who consent to participate in the study will complete the Participant Information Form and the HPV Knowledge and Vaccination Intention Scale before receiving any education. This stage aims to determine participants' baseline knowledge and intention to vaccinate.
2 secondary outcomes
HPV Knowledge and Vaccination Intention - Post-Education Test
Time frame: Immediately after education
HPV Knowledge and Vaccination Intention - 1-Month Follow-Up Test
Time frame: : 1 month after education
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 19 Aug 2026.
- Individual participant dataSharing planned: No. Individual participant data will not be shared because the dataset contains sensitive personal information related to participants' health, vaccination intention, and demographic details. To protect participant confidentiality and privacy, access to the data is restricted to the research team.
Related trials for Human Papillomavirus (HPV) Infection
Not yet recruitingPhase 1/2
Clinical Trial to Assess the Safety, Tolerability, Reactogenicity, and Immunogenicity of a 10 Valent Human Papillomavirus Virus (10vHPV) Vaccine
Human Papillomavirus Infection
Active, not recruitingPhase 4
Comparing Immune Response of 2 vs 3 HPV Doses (27-45 Years Old)
Immunization, HPV Infection
Not yet recruitingPhase 2
Combination Bevacizumab and PRGN-2012 in Adults With Recurrent Respiratory Papillomatosis (RRP)
Respiratory Recurrent Papillomatosis (RRP), Human Papillomavirus (HPV)
RecruitingPhase 2
A Study of the Preliminary Efficacy of DARE-HPV to Treat High-risk Persistent Human Papillomavirus (hrHPV)
Human Papilloma Virus (HPV), High-risk Human Papillomavirus Infection
RecruitingPhase 2
A Single Arm Phase II Trial in p16-positive Oropharynx Cancer of Selective Dose De-escalation of nodAl VolumEs at Minimal Risk and Primary Site Disease (SAVED)
Head and Neck Cancer, Head and Neck Squamous Cell Cancer
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Video-Based HPV Education and Face-to-Face HPV Education in people with Human Papillomavirus (HPV) Infection and HPV Vaccination Acceptance/Intention, run by Emel GÜÇLÜ CİHAN at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 8 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 19 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
HPV Knowledge and Vaccination Intention - Pre-Test (time frame: Before education). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Aug 2026.